NCT03630939View on ClinicalTrials.gov

A Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Topical ESR-114 in Subjects With Plaque Psoriasis

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

104

Participants

Timeline

Start Date

August 9, 2018

Primary Completion Date

June 5, 2019

Study Completion Date

June 12, 2019

Conditions
Psoriatic Plaque
Interventions
DRUG

ESR-114

ESR-114 Topical Gel

OTHER

Placebo

Placebo Topical Gel

Trial Locations (10)

27612

Study Site 14, Raleigh

33624

Study Site 16, Tampa

55432

Study Site 17, Fridley

77056

Study Site 15, Houston

77845

Study Site 11, College Station

78213

Study Site 18, San Antonio

78759

Study Site 12, Austin

90404

Study Site 19, Santa Monica

K9J 5K2

Study Site 13, Peterborough

H2K 4L5

Study Site 10, Montreal

Sponsors

Collaborators (1)

Innovaderm Research Inc.
All Listed Sponsors
collaborator

Innovaderm Research Inc.

OTHER

lead

Escalier Biosciences B.V.

INDUSTRY

NCT03630939 - A Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Topical ESR-114 in Subjects With Plaque Psoriasis | Biotech Hunter | Biotech Hunter